| 1995 |
hSRP1α (KPNA3 alias) binds in vitro directly and specifically to substrates containing either a simple or bipartite NLS motif, promotes docking of import substrates to the nuclear envelope, and together with recombinant human Ran reconstitutes complete nuclear protein import in vitro, establishing it as a cytosolic receptor for NLS motifs. |
In vitro NLS-binding assay, nuclear envelope docking assay, in vitro nuclear import reconstitution with recombinant proteins |
Science |
High |
7754385
|
| 1996 |
A short conserved amino-terminal domain of hSRP1α is necessary and sufficient for interaction with the p97 (importin β) subunit; fusion of this domain to a cytoplasmic reporter is sufficient to promote complete nuclear import, and addition of the domain alone inhibits import of NLS-containing proteins in vitro. Full-length hSRP1α can exit the nucleus, but the amino-terminal domain alone cannot, establishing hSRP1α as an adaptor tethering NLS substrates to the import machinery via its N-terminal p97-binding domain. |
Deletion mutagenesis, in vitro nuclear import inhibition assay, reporter fusion import assay, in vivo nuclear exit assay |
The EMBO journal |
High |
8617227
|
| 1997 |
hSRP1γ (KPNA3) can form a complex with importin β and mediates import of a BSA-NLS substrate in an in vitro nuclear import system, demonstrating its functional activity as an importin α adaptor. |
Complex formation assay, in vitro nuclear import assay with BSA-NLS substrate |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
9435235
|
| 1997 |
KPNA3 (Qip1/hSrp1) interacts with DNA helicase Q1/RecQL via a putative NLS in Q1; unlike hSrp1, Qip1 and Rch1 but not hSrp1 interact with the Q1 NLS in two-hybrid assays, indicating isoform-specific substrate discrimination among importin α family members. |
Yeast two-hybrid screening, GST pulldown from human cell lysates |
Biochemical and biophysical research communications |
Medium |
9168958
|
| 1997 |
KPNA3 (hSRP1) binds proliferation-related nucleolar protein p120 through p120's NLS (amino acids 96–119) and requires the C-terminus of hSRP1 (amino acids 453–491); interaction confirmed by yeast two-hybrid and co-expression in Sf9 cells. |
Yeast two-hybrid screen, deletion mutagenesis, co-expression/co-immunoprecipitation in Sf9 insect cells |
Chromosoma |
Medium |
9211983
|
| 2015 |
KPNA3 in Bombyx mori interacts directly with heat shock transcription factor (HSF) and transports it into the nucleus; KPNA3 knockdown eliminates the second HSP mRNA expression peak at 24 h after heat shock without reducing HSF protein levels, demonstrating that KPNA3-mediated nuclear import of HSF is required for the late heat shock response. |
Pull-down assay from tissue lysates, GST-pulldown with recombinant proteins, RNAi knockdown with mRNA quantification |
Gene |
Medium |
26367326
|
| 2021 |
KPNA3 variants associated with hereditary spastic paraplegia show altered expression levels, subcellular distribution, and protein interaction, implicating dysfunctional nucleocytoplasmic shuttling as a pathomechanism for HSP. |
Trio whole-exome sequencing, bioinformatics, cellular and biochemical assays measuring protein expression, subcellular localization, and protein interaction |
Annals of neurology |
Medium |
34564892
|
| 2021 |
The N-terminal domain (1–40 aa) of FAdV-4 Fiber-2 protein interacts with KPNA3/4; overexpression of KPNA3/4 enhances FAdV-4 replication, while knockout reduces it; deletion of residues 7–40 in Fiber-2 attenuates the virus, demonstrating KPNA3 assists nuclear import-dependent viral replication. |
Co-interaction assay, KPNA3/4 overexpression and CRISPR-Cas9 knockout, rescue of virus with Fiber-2 deletion mutant, in vitro and in vivo replication assays |
Virulence |
Medium |
33616472
|
| 2023 |
miR-26a inhibits nuclear translocation of NF-κB p65 by targeting KPNA3; KPNA3 mediates p65 nuclear import in OA chondrocytes, and p65 transcriptionally activates LOC727924, forming a p65-LOC727924-miR-26a/KPNA3-p65 regulatory loop. |
miRNA inhibitor/mimic experiments, KPNA3 knockdown/overexpression, nuclear/cytoplasmic fractionation, luciferase reporter, in vivo DMM mouse model with immunostaining |
International immunopharmacology |
Medium |
37392568
|
| 2024 |
KPNA3 specifically drives nuclear import of NPAT by binding its NLS, and simultaneously sterically blocks a C-terminal self-interaction facilitator (C-SIF) motif-dependent NPAT self-association, thereby suppressing aberrant cytoplasmic NPAT phase separation/condensation and enabling proper histone locus body (HLB) formation in the nucleus. |
Co-immunoprecipitation, in vitro nuclear import assay, phase separation/condensation assays, deletion and domain-mapping mutagenesis, live-cell imaging, structural modeling |
The Journal of cell biology |
High |
39621428
|
| 2025 |
KPNA3 mediates nuclear import of transcription factors TFEB and CREB in Schwann cells; SDF2L1 knockdown reduces KPNA3 expression, impairing TFEB and CREB nuclear accumulation and consequently suppressing autophagy and neurotrophin expression; KPNA3 overexpression rescues these deficits. |
Proteomics, KPNA3 knockdown/overexpression, nuclear/cytoplasmic fractionation, in vivo SDF2L1 KO mouse model |
Experimental neurology |
Medium |
40294738
|
| 2026 |
KPNA3/importin α4 specifically governs Runx2 nuclear import; depletion of KPNA3 inhibits osteoblast differentiation. The polyQ repeat of Runx2 keeps the NLS accessible for KPNA3 binding; polyQ deletion causes folding of the N-terminus (blocking KPNA3 access) and leads to aberrant cytoplasmic Runx2 aggregation. KPNA3 also modulates Runx2 liquid-like condensate state. |
KPNA3 depletion (KO/KD), co-immunoprecipitation, nuclear import assays, structural modeling, condensation/phase-separation assays, osteoblast differentiation assay |
Cell reports |
High |
41903133
|
| 2026 |
KPNA3 knockdown in multiple myeloma cells inhibits ALDH2 transcription and downregulates hedgehog pathway activity; ivermectin binds directly to KPNA3, reduces KPNA3 protein levels, and promotes MM cell apoptosis. |
KPNA3 knockdown (in vitro and in vivo), drug-binding assay (ivermectin-KPNA3 direct binding), pathway activity measurements, apoptosis assays |
Apoptosis |
Medium |
41813919
|